[123I]IPCIT and [123I]beta-CIT as SPECT tracers for the dopamine transporter: a comparative analysis in nonhuman...

Area of Science:

• Neuroscience
• Radiochemistry
• Pharmacology

Background:

• Dopamine transporter (DAT) imaging is crucial for studying neurological disorders.
• Phenyltropane derivatives like [123I]-CIT and [123I]PCIT are used as DAT imaging agents.
• Accurate quantification of DAT availability is essential for reliable diagnostic and research applications.

Purpose of the Study:

• To compare the performance of [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)tropane ([123I]-CIT) and its analog [123I]PCIT for dopamine transporter imaging.
• To evaluate the accuracy of compartmental modeling versus a peak equilibrium method for quantifying striatal distribution volumes.
• To assess the impact of tracer selectivity on imaging outcomes.

Main Methods:

• Single photon emission computed tomography (SPECT) was employed in nonhuman primates.
• Two phenyltropane derivatives, [123I]-CIT and [123I]PCIT, were administered.
• Data analysis involved compartmental modeling and a peak equilibrium method.

Main Results:

• Both [123I]-CIT and [123I]PCIT demonstrated high affinity for the dopamine transporter.
• Despite higher selectivity of [123I]PCIT for DAT, similar striatal distribution volumes were observed for both tracers.
• The peak equilibrium method significantly overestimated striatal distribution volumes compared to compartmental modeling.

Conclusions:

• Compartmental modeling provides a more accurate estimation of striatal distribution volumes than the peak equilibrium method.
• The overestimation by the peak equilibrium method is attributed to differences in the calculated time of peak specific uptake.
• These findings underscore the importance of employing appropriate kinetic modeling for accurate dopamine transporter imaging.